680 results on '"Giuliano, Mario"'
Search Results
2. Crosslink between atrial fibrillation and cancer: a therapeutic conundrum
3. COVID-19 in patients with thymic epithelial tumors with or without Good’s syndrome: a single-center retrospective study
4. Measurement of resting energy expenditure and its accuracy in women with breast cancer
5. DLL3 as a potential diagnostic and therapeutic target in neuroendocrine neoplasms: A narrative review
6. Reawakening the master switches in triple-negative breast cancer: A strategic blueprint for confronting metastasis and chemoresistance via microRNA-200/205: A systematic review
7. Gender minorities in breast cancer – Clinical trials enrollment disparities: Focus on male, transgender and gender diverse patients
8. Central obesity, body mass index, metabolic syndrome and mortality in Mediterranean breast cancer patients
9. Analysis of circulating extracellular vesicle derived microRNAs in breast cancer patients with obesity: a potential role for Let-7a
10. Effects of 3D Scans on Veterinary Students’ Learning Outcomes Compared to Traditional 2D Images in Anatomy Classes
11. Association of tumor-infiltrating lymphocytes with recurrence score in hormone receptor-positive/HER2-negative breast cancer: Analysis of four prospective studies
12. Evolving treatments and outcomes in HER2-Positive metastatic breast cancer: Data from the GIM14/BIOMETA study
13. Estrogen deprivation effects of endocrine therapy in breast cancer patients: Incidence, management and outcome
14. Impaired Seroconversion After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccine in Patients With Thymic Epithelial Tumors
15. High FOXA1 levels induce ER transcriptional reprogramming, a pro-metastatic secretome, and metastasis in endocrine-resistant breast cancer
16. Toxicity profile of antibody-drug conjugates in breast cancer: practical considerations
17. The evolving therapeutic landscape of trastuzumab-drug conjugates: Future perspectives beyond HER2-positive breast cancer
18. New steps on an old path: Novel estrogen receptor inhibitors in breast cancer
19. Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial
20. Efficacy of PARP inhibitors in advanced high-grade serous ovarian cancer according to BRCA domain mutations and mutation type.
21. Metastatic Breast Cancer
22. Endocrine Therapy
23. Assessment of Total, PTEN–, and AR-V7+ Circulating Tumor Cell Count by Flow Cytometry in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Enzalutamide
24. A review of the use of next generation sequencing methodologies to identify biomarkers of resistance to CDK4/6 inhibitors in ER+/HER2- breast cancer
25. REThinking the role of the RET oncogene in breast cancer.
26. Effects of 3D Scans on Veterinary Students' Learning Outcomes Compared to Traditional 2D Images in Anatomy Classes.
27. Exploring the interplay between Kaposi's sarcoma and SARS‐CoV‐2 infection: A case series and systematic review.
28. Case report: Potential role of immunotherapy in thymic malignancies: a unique case of a durable and complete response upon an immune checkpoint inhibitor.
29. Optimising triage procedures for patients with cancer needing active anticancer treatment in the COVID-19 era
30. Serum biomarkers of inflammation and vascular damage upon SARS-Cov-2 mRNA vaccine in patients with thymic epithelial tumors
31. Blockade of AP-1 Potentiates Endocrine Therapy and Overcomes Resistance
32. AB012. The potential role of innate lymphoid cells in thymic epithelial tumors
33. AB003. Unexpected long-lasting control of thymic carcinoma treated with anti-PD1 and oral etoposide: a real-life experience of combination therapy
34. AB013. Occurrence and severity of COVID-19 in patients affected by thymic epithelial tumors with or without Good’s syndrome: a single centre experience
35. Expression of vimentin, TPI and MAT2A in human dermal microvascular endothelial cells during angiogenesis in vitro.
36. Neratinib plus trastuzumab is superior to pertuzumab plus trastuzumab in HER2-positive breast cancer xenograft models
37. PONDx: real-life utilization and decision impact of the 21-gene assay on clinical practice in Italy
38. Composite risk and benefit from adjuvant dose-dense chemotherapy in hormone receptor-positive breast cancer
39. Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis
40. Metastatic Breast Cancer
41. Endocrine Therapy
42. The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper
43. Task force veterinary anatomy: joint efforts of the five German veterinary schools to ensure education during the COVID-19 pandemic
44. miRNAs in the Box: Potential Diagnostic Role for Extracellular Vesicle-Packaged miRNA-27a and miRNA-128 in Breast Cancer
45. Human epidermal growth factor receptor 2 dual blockade with trastuzumab and pertuzumab in real life: Italian clinical practice versus the CLEOPATRA trial results
46. Immunocytometric analysis of patients with thymic epithelial tumors revealed that COVID-19 vaccine booster strongly enhanced the immune response
47. R0 surgical resection of giant dedifferentiated retroperitoneal liposarcomas in the COVID era with and without nephrectomy: A case report
48. Central Obesity, Body Mass Index, Metabolic Syndrome and Mortality in Mediterranean Breast Cancer Patients
49. The effect of the alpha-specific PI3K inhibitor alpelisib combined with anti-HER2 therapy in HER2+/PIK3CA mutant breast cancer
50. Ribociclib in newly diagnosed hepatitis B infection: A case report
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.